Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Therapeutic Areas
Therapeutic Areas: Dermatology | Rheumatology | Family Medicine
 Disease Category: Psoriasis and Psoriatic Disorders
Location: United States, CA

Trial Information

A Phase 3, Multi-site, randomized, mixed-blind, parallel-group treatment withdrawl and re-treatment study of the efficacy and safety of 2 oral doses of CP-690,550 in Subjects with Moderate to Severe Chronic Plaque Psoriasis

Patient Inclusion Criteria:

  • 18+ years of age
  • Diagnosis of stable plaque psoriasis
  • Moderate to severe
  • Covering at least 10% of total body surface area

Patient Exclusion Criteria:

  • Currently have non-plaque forms of psoriasis, eg, erythrodermic, guttate, or pustular psoriasis

Dermatology Specialists, Inc.
3629 Vista Way
Oceanside, CA 92056
Phone: 760-757-7546
Email: research2@dermspec.com

View Map

Research Center Information: Dermatology Specialists, Inc.

If you would like to learn more about participating in this study, please send an email message using the form below.

Name:
Address:
City:
State:
Country:
Phone:
Email:  
Message:
 

DISCLAIMER: This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.